Citations 2
Patient-reported Outcomes Through 12-weeks of Double-blind Rimegepant Treatment for the Prevention of Episodic Migraine in Adults with Prior Inadequate Response to Oral Preventatives (P1-15.008)
Starling, Amaal, Versijpt, Jan, Aslan, Ayşe Neslihan, Seehra, Harpreet, Ramaker, Sara Anne, McCollum, Shannin, Thiry, Alexandra, Abraham, Lucy, Fountaine, Robert, Ramirez, Luz, Versijpt, Jan J. , Sumelahti, Marja‐Liisa , Ramaker, Sara , Thiry, Alexandra, Abraham, Lucy , Fountaine, Robert J.
Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available
Reasons for Discontinuing Triptans Among Current Users of Rimegepant for the Acute Treatment of Migraine in the CONFIDENCE Study (P8-15.018)
Lipton, Richard, Goadsby, Peter; id_orcid 0000-0003-3260-5904, Pozo-Rosich, Patricia, Schwedt, Todd, Fanning, Kristina, Abraham, Lucy, Blakeman, Karin Hygge , Urani, Alexandre , Lambru, Giorgio , Pozo‐Rosich, Patricia , Schwedt, Todd J. , Fanning, Kristina M. , Dai, Feng , Abraham, Lucy
Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available